Literature DB >> 22017771

Ring versus 'Mercedes-Benz' cartilage-perichondrium graft tympanoplasty in management of pars tensa cholesteatoma.

O A Albirmawy1.   

Abstract

OBJECTIVE: To compare anatomical and audiological outcomes of ring versus 'Mercedes-Benz' cartilage-perichondrium graft tympanoplasty in patients with pars tensa cholesteatoma. STUDY
DESIGN: Prospective clinical study.
SETTING: Otolaryngology department, Tanta University Hospital, Egypt. PATIENTS AND METHODS: Over three years, 60 ears in 60 patients underwent surgery for either sinus or tensa retraction cholesteatoma, reconstructed using either a ring-shaped (30 ears) or Mercedes-Benz symbol shaped (30 ears) cartilage-perichondrium graft, with at least two years' follow up. Post-operative drum perforation and retraction, cholesteatoma residue and recurrence, middle-ear effusion, and hearing acuity were monitored.
RESULTS: Anatomical outcomes were equivalent in both groups, but slightly better in the Mercedes group. Hearing improved significantly in both groups (pre- vs post-operative results), but significantly more so in the ring group. Within-group hearing outcomes were unaffected by cholesteatoma type or tympanoplasty type.
CONCLUSION: The Mercedes-Benz technique may be superior to the ring technique in preventing neodrum retraction. However, the ring graft technique had better hearing outcomes, perhaps due to its more physiological design.

Entities:  

Mesh:

Year:  2011        PMID: 22017771     DOI: 10.1017/S0022215111002593

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  A new grafting technique for tympanoplasty: tympanoplasty with a boomerang-shaped chondroperichondrial graft (TwBSCPG).

Authors:  Rıza Dündar; Fatih Kemal Soy; Erkan Kulduk; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-16       Impact factor: 2.503

2.  Tympanomastoidectomy for cholesteatoma among Nigerians.

Authors:  A D Olusesi; E Opaluwah
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-16       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.